End Stage Renal Disease: Clinical Trials

615 trials for End Stage Renal Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

396 completed, 91 unknown, 45 terminated, 31 recruiting. 259 Not applicable, 107 Phase 2, 59 Phase 4, 56 Phase 3, 47 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable259Completed 161, Unknown 41, Terminated 19, Recruiting 16, Active not recruiting 9, Withdrawn 7, Not yet recruiting 3, Enrolling by invitation 2, Suspended 1
Phase 2107Completed 71, Terminated 14, Unknown 14, Recruiting 3, Withdrawn 3, Not yet recruiting 2
Phase 459Completed 35, Unknown 9, Withdrawn 6, Active not recruiting 4, Terminated 4, Suspended 1
Phase 356Completed 39, Unknown 9, Recruiting 3, Terminated 2, Withdrawn 2, Active not recruiting 1
Phase 147Completed 35, Terminated 5, Not yet recruiting 2, Recruiting 2, Unknown 2, Withdrawn 1
Early Phase 15Completed 3, Withdrawn 2

Follow End Stage Renal Disease: new trials by email Literature Review of End Stage Renal Disease trials Research Report on End Stage Renal Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BicMag Study - Improving Mineral Buffering Capacity in Dialysis Patients
D-Standard, D-Bic, D-Mag - End Stage Renal Disease
Not applicableNot yet recruitingElisabethinen Hospital912026-10-012026-06-23
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Ribupatide - End Stage Renal Disease, Renal Impairment
Phase 1RecruitingKailera322026-09-082026-10-01
Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease
ChoironeX GalKO Porcine Thymokidney - End Stage Renal Disease
Phase 1Not yet recruitingXeno Holdings (US), LLC dba ChoironeX42026-09-012026-09-02
Development and Test of a Communication Skills Training for Transplant Providers - Aims 2 & 3
EPPComm Provider Training - Kidney Disease, Chronic, End Stage Renal Disease
Not applicableNot yet recruitingTemple University702026-09-012026-06-12
Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
Bupropion Hydrochloride 150 MG - End Stage Renal Disease, Fatigue
Phase 1 / Phase 2Not yet recruitingThe University of Texas Health Science Center at San Antonio162026-08-242026-08-11
Pumpkin Seed Oil as a Nutraceutical for Hemodialysis Patients
Pumpkin Seed Oil 1000 mg, Standard hemodialysis care - End Stage Renal Disease, Chronic Kidney Disease Requiring Chronic Dialysis
Not applicableRecruitingAl-Mustansiriyah University1002026-07-202026-07-17
The Effect of Intradialytic Eye Exercise in Hemodialysis Patients
Intradialytic Eye Exercise - End Stage Renal Disease, Hemodialysis Complication
Not applicableEnrolling by invitationPardis Specialized Wellness Institute302026-06-012026-09-01
Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
Pegcetacoplan, Placebo - Delayed Graft Function, End Stage Renal Disease
Phase 3WithdrawnApellis Pharmaceuticals, Inc.2026-05-182026-09-02
Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients.
No systematic monitoring of symptoms, Systematic monitoring of symptoms - End Stage Renal Disease
Not applicableRecruitingCentral Hospital, Nancy, France22932026-02-062026-02-13
Light Therapy in End Stage Kidney Disease
Bright light, Dim Light - End Stage Renal Disease
Not applicableCompletedUniversity of Pennsylvania82026-02-012026-10-19
Solv Multi-Pass Hemodialysis System In-Center Clinical Study
Solv Multi-Pass Hemodialysis System - End Stage Renal Disease
Not applicableTerminatedMozarc Medical US LLC42026-01-132026-10-01
Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
Hemodialysis or Hemodiafiltration either with sodium zero-diffusive treatment or standard treatment without sodium-control - End Stage Renal Disease
Not applicableRecruitingFresenius Medical Care Deutschland GmbH1302025-12-162025-12-22
Drug Interaction Potential of Pro-Inflammatory Conditions
None (Observational) - Diabetes Mellitus, Type 2, End Stage Renal Disease
RecruitingIndiana University1502025-11-012026-01-22
Premarket Clinical Safety Assessment of the ELISIO™-HX
ELISIO™-HX Dialyzer - Renal Failure, Acute Renal Failure
Not applicableCompletedNipro Medical Corporation222025-09-082026-09-03
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
HeRO® Graft System or Super HeRO® System - End Stage Renal Disease, Hemodialysis Access Failure
RecruitingMerit Medical Systems, Inc.1002025-07-282026-06-01
Blood Flow Conditions and Sounds in AVFs
MRI acquisition, US examination - End Stage Renal Disease
Not applicableRecruitingMario Negri Institute for Pharmacological Research152025-03-012025-09-04
Ventilatory Functions and Physical Intolerance in ESRD Adolescents: Response to Program of Walking With Dogs
incentive spirometer and walking with dog, training by incentive spirometer only - End Stage Renal Disease, Hemolysis
Not applicableRecruitingCairo University402025-02-052025-03-06
The Effect of Home Based Tele-Exercise on Peritoneal Dialysis Patients
Home-based Tele Exercise - End Stage Renal Disease, Peritoneal Dialysis Complication
Not applicableCompletedPardis Specialized Wellness Institute302025-01-292025-08-12
CAPABLE Transplant
CAPABLE Transplant- Open Label Pilot, CAPABLE Transplant- Randomized Control Trial - Quality of Life, Depression
Not applicableRecruitingJohns Hopkins University432025-01-252026-07-20
Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
VasQ, Arteriovenous fistula creation for dialysis vascular access - End Stage Renal Disease
Not applicableRecruitingLaminate Medical Technologies3002025-01-132026-10-27

Showing 20 of 615. Sign in to see all of them.

Narrower conditions

Kidney Failure, Chronic (615)  ·  Renal Insufficiency, Chronic (72)  ·  Renal Insufficiency (43)  ·  Kidney Diseases (30)  ·  Cardiovascular Diseases (17)  ·  Inflammation (17)  ·  Arteriovenous Fistula (16)  ·  Anemia (14)  ·  Hyperparathyroidism, Secondary (12)  ·  Diabetes Mellitus (11)  ·  Motor Activity (11)  ·  Hyperphosphatemia (10)  ·  Heart Failure (9)  ·  Depression (8)  ·  Thrombosis (8)

Broader conditions

Disease Attributes (615)  ·  Female Urogenital Diseases (615)  ·  Female Urogenital Diseases and Pregnancy Complications (615)  ·  Male Urogenital Diseases (615)  ·  Pathologic Processes (615)  ·  Pathological Conditions, Signs and Symptoms (615)  ·  Chronic Disease (614)  ·  Urologic Diseases (613)  ·  Urogenital Diseases (612)  ·  Kidney Diseases (585)  ·  Renal Insufficiency (572)  ·  Renal Insufficiency, Chronic (543)  ·  Nutritional and Metabolic Diseases (72)  ·  Cardiovascular Diseases (63)  ·  Metabolic Diseases (57)

Interventions

Cinacalcet (10)  ·  Exercise (10)  ·  Tacrolimus (9)  ·  Blood Specimen Collection (8)  ·  Renal Dialysis (8)  ·  spleen fibrinolytic proteinase (human) (8)  ·  ferric pyrophosphate (7)  ·  Dietary Supplements (6)  ·  ferric citrate (6)  ·  Heparin (5)  ·  Kidney Transplantation (5)  ·  Mycophenolic Acid (5)  ·  Calcitriol (4)  ·  Cholecalciferol (4)  ·  Cognitive Behavioral Therapy (4)

Sponsors

Vanderbilt University (13)  ·  Amgen (12)  ·  Vantive Health LLC (12)  ·  Rockwell Medical Technologies, Inc. (10)  ·  Fresenius Medical Care Deutschland GmbH (8)  ·  Massachusetts General Hospital (8)  ·  Pardis Specialized Wellness Institute (8)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (7)  ·  Ain Shams University (6)  ·  Cardenal Herrera University (6)  ·  Johns Hopkins University (6)  ·  Satellite Healthcare (6)  ·  Columbia University (5)  ·  NYU Langone Health (5)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5)

Countries

United States (267)  ·  Canada (38)  ·  United Kingdom (28)  ·  France (24)  ·  Germany (24)  ·  China (22)  ·  Italy (20)  ·  Belgium (14)  ·  South Korea (14)  ·  Spain (14)  ·  Iran (11)  ·  Israel (11)  ·  Egypt (10)  ·  Switzerland (10)  ·  Taiwan (10)

Top investigators

Alp Ikizler, MD (11)  ·  Mohammad Ali Tabibi, Dr (6)  ·  Adrian Ebner, MD (5)  ·  Adam Ogna, MD (3)  ·  Aditi Gupta, MD (3)  ·  Arduino Arduini, MD (3)  ·  Jonathan Himmelfarb, MD (3)  ·  Peter Kotanko, MD (3)  ·  Raymond D Pratt, MD FACP (3)  ·  Valentina Forni Ogna, MD (3)  ·  Alan S. Kliger, M.D. (2)  ·  Alistair J Ingram, MD (2)  ·  Amy D Waterman, PhD (2)  ·  Ashwini Sehgal, MD (2)

Results publications

PMID 32390133, PMID 33586138, PMID 35018639, PMID 36472884, PMID 37651553, PMID 38189593, PMID 38899545, PMID 40576086, PMID 19339093, PMID 21564530, PMID 22422538, PMID 23137211, PMID 23149295, PMID 23332990, PMID 23970131, PMID 24011252, PMID 25136843, PMID 25293374, PMID 26463883, PMID 27587605, PMID 28094031, PMID 28301073, PMID 28506446, PMID 28910799, PMID 29621747, PMID 31826326, PMID 33283264, PMID 36472416, PMID 37916745, PMID 11562419, PMID 11739090, PMID 12490682, PMID 14678952, PMID 15213282, PMID 15327420, PMID 15384829, PMID 15385656, PMID 15450042, PMID 15689407, PMID 15806502, PMID 15930998, PMID 16034410, PMID 16105056, PMID 16459764, PMID 16724235, PMID 16758521, PMID 16775236, PMID 17167117, PMID 17699221, PMID 17848650

NIH funding

2019 (3), R01DK045604 (3), R01NR017018 (2), R34HL140477 (2), U01DK066597 (2), 2004 (1), 2009 (1), 2014 (1), 2015 (1), 2017 (1), 2018 (1), 2023 (1), 5RC2DK122397 (1), I01CX002009 (1), I01HX002639 (1)